We are live on
!
Find out more
CCM
Chiron Capital Management Portfolio holdings
AUM
$111M
This Fund
S&P 500
This Quarter
Est. Return
+4.74%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$120M
AUM Growth
+$2.19M
(+1.9%)
Cap. Flow
-$3.94M
Cap. Flow
% of AUM
-3.29%
Top 10 Holdings %
Top 10 Hldgs %
60.7%
Holding
85
New
13
Increased
24
Reduced
35
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$2.38M |
| 2 |
AFGR
First Trust Active Factor Large Cap Growth ETF
AFGR
|
+$1.64M |
| 3 |
AT&T
T
|
+$1.48M |
| 4 |
Teladoc Health
TDOC
|
+$1.15M |
| 5 |
Sherwin-Williams
SHW
|
+$1.13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$6.58M |
| 2 |
CVS Health
CVS
|
+$2.45M |
| 3 |
Kraft Heinz
KHC
|
+$2.25M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$2.08M |
| 5 |
ExxonMobil
XOM
|
+$1.02M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 54.13% |
| 2 | Miscellaneous | 14.93% |
| 3 | Technology | 7.99% |
| 4 | Energy | 5.25% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Bristol-Myers Squibb
BMY
$132B
| $44.4M | 36.97% |
664,082
-100,971
| -13% | -$6.58M |
|
2
Gilead Sciences
GILD
$182B
| $8.21M | 6.84% |
119,206
-4,589
| -4% | -$306K |
|
3
Pfizer
PFE
$158B
| $5.27M | 4.39% |
134,509
-19,320
| -13% | -$751K |
|
|
4
AT&T
T
$175B
| $3.01M | 2.51% |
138,553
+64,923
| +88% | +$1.48M |
|
|
SPLK
5
DELISTED
Splunk Inc
SPLK
| $2.48M | 2.07% |
17,150
+8,900
| +108% | +$1.13M |
|
|
CTXS
6
DELISTED
Citrix Systems Inc
CTXS
| $2.24M | 1.87% |
+19,100
| New | +$2.38M |
|
7
First Trust Enhanced Short Maturity ETF
FTSM
$6.55B
| $2.05M | 1.71% |
34,159
-2,481
| -7% | -$149K |
|
8
Intel
INTC
$552B
| $1.8M | 1.5% |
32,114
-2,000
| -6% | -$117K |
|
|
AFGR
9
First Trust Active Factor Large Cap Growth ETF
AFGR
$92.7M
| $1.72M | 1.43% |
+64,917
| New | +$1.64M |
|
|
10
Sherwin-Williams
SHW
$79.2B
| $1.7M | 1.42% |
6,242
+4,142
| +197% | +$1.13M |
|
11
First Trust Managed Municipal ETF
FMB
$2.04B
| $1.67M | 1.39% |
29,213
+2,133
| +8% | +$122K |
|
12
Home Depot
HD
$313B
| $1.62M | 1.35% |
5,085
-400
| -7% | -$127K |
|
13
Merck
MRK
$366B
| $1.62M | 1.35% |
20,850
-1,787
| -8% | -$133K |
|
14
AB InBev
BUD
$157B
| $1.59M | 1.32% |
22,060
-12,110
| -35% | -$883K |
|
15
Amazon
AMZN
$2.77T
| $1.55M | 1.29% |
9,020
-300
| -3% | -$49.9K |
|
16
Apple
AAPL
$4.61T
| $1.39M | 1.16% |
10,159
+297
| +3% | +$38.5K |
|
17
Enterprise Products Partners
EPD
$83.9B
| $1.32M | 1.1% |
54,525
-761
| -1% | -$18K |
|
18
First Trust Smith Opportunistic Fixed Income ETF
FIXD
$3.19B
| $1.27M | 1.06% |
23,703
+3,843
| +19% | +$205K |
|
19
SLB Ltd
SLB
$84.7B
| $1.26M | 1.05% |
39,230
-11,770
| -23% | -$362K |
|
20
Aflac
AFL
$57.7B
| $1.23M | 1.02% |
22,832
-355
| -2% | -$19.4K |
|
21
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.46B
| $1.22M | 1.02% |
24,034
+2,674
| +13% | +$137K |
|
22
Raymond James Financial
RJF
$34B
| $1.21M | 1.01% |
13,950
-300
| -2% | -$26.1K |
|
|
23
Teladoc Health
TDOC
$1.14B
| $1.19M | 0.99% |
+7,124
| New | +$1.15M |
|
24
State Street SPDR S&P Biotech ETF
XBI
$11.3B
| $1.15M | 0.96% |
8,511
+5,692
| +202% | +$748K |
|
25
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.63B
| $1.09M | 0.9% |
22,381
+4,371
| +24% | +$213K |
|
Similar funds
LA
MASM
WCBA
RM
IMT
RQS
VDC
TBFA
Chiron Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Chiron Capital Management held 85 positions worth $120M, up 1.9% from $118M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Chiron Capital Management withdrew a net $3.94M in Q2 2021, closing 6 positions and reducing 35 holdings. Its most notable exit was Kraft Heinz, an estimated $2.25M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 54% of assets, down from 59% a quarter earlier, followed by Miscellaneous and Technology.
Against the trend, Chiron Capital Management opened a new position in Citrix Systems Inc worth $2.24M.
- Chiron Capital Management's largest Q2 2021 buy was Citrix Systems Inc: 19,100 shares worth $2.24M.
- Chiron Capital Management added most to AT&T in Q2 2021, an estimated $1.48M increase.
- Chiron Capital Management's biggest Q2 2021 reduction was Bristol-Myers Squibb, cutting an estimated $6.58M.
- Chiron Capital Management fully exited Kraft Heinz in Q2 2021, selling an estimated $2.25M.
- Chiron Capital Management's ten largest holdings make up 61% of its $120M portfolio in Q2 2021.
- Chiron Capital Management opened 13 new positions and closed 6 in Q2 2021.
- Chiron Capital Management's portfolio value rose 1.9% quarter-over-quarter to $120M.
Based on Chiron Capital Management's 13F filing for Q2 2021, filed 20 Jul 2021.